Mainland China’s 17 million Alzheimer’s patients can, for the first time, pay less out of pocket for a costly drug…
Read More »Pfizer
A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a…
Read More »
American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…
Read More »
In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden…
Read More »
Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…
Read More »
GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a…
Read More »
A potential multibillion-dollar deal unveiled on Friday by CSPC Pharmaceutical Group is the latest in a growing number of agreements…
Read More »
Chinese drug maker 3SBio has licensed its new cancer drug to US pharmaceutical giant Pfizer in the largest deal ever…
Read More »
A total of 80 top executives from global multinational companies are set to gather in Beijing to discuss a range…
Read More »
After Britain became the first country to grant emergency approval on Wednesday to a coronavirus vaccine developed by Pfizer and…
Read More »